Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content - Vascular endothelial growth factor decreases occludin in retinal endothelial cells

被引:461
作者
Antonetti, DA
Barber, AJ
Khin, S
Lieth, E
Tarbell, JM
Gardner, TW
机构
[1] Penn State Univ, Penn State Geisinger Hlth Syst, Coll Med, Ulerich Ophthalmol Res Ctr,Dept Ophthalmol, Hershey, PA 17033 USA
[2] Penn State Univ, Penn State Geisinger Hlth Syst, Coll Med, Ulerich Ophthalmol Res Ctr,Dept Cellular & Mol Ph, Hershey, PA 17033 USA
[3] Penn State Univ, Penn State Geisinger Hlth Syst, Coll Med, Ulerich Ophthalmol Res Ctr,Dept Neurosci & Anat, Hershey, PA 17033 USA
[4] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA
关键词
D O I
10.2337/diabetes.47.12.1953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Blood-retinal barrier (BRB) breakdown is a hallmark of diabetic retinopathy, but the molecular changes that cause this pathology are unclear. Occludin is a transmembrane component of interendothelial tight junctions that may regulate permeability at the BRB. In this study, we examined the effects of vascular endothelial growth factor (VEGF) and diabetes on vascular occludin content and barrier function. Sprague-Dawley rats were made diabetic by intravenous streptozotocin injection, and age-matched animals served as controls. After 3 months, BRB permeability was quantified by intravenous injection of fluorescein isothiocyanate-bovine serum albumin (FITC-BSA), M-r 66 kDa, and 10-kDa rhodamine-dextran (R-D), followed by digital image analysis of retinal sections. Retinal fluorescence intensity for FITC-BSA increased 62% (P less than or equal to 0.05), but R-D fluorescence did not change significantly Occludin localization at interendothelial junctions was confirmed by immunofluorescence, and relative protein content was determined by immunoblotting of retinal homogenates, Retinal occludin content decreased -35% (P less than or equal to 0.03) in the diabetic versus the control animals, whereas the glucose transporter GLUT1 content was unchanged in rat retinas. Additionally, treatment of bovine retinal endothelial cells in culture with 0.12 nmol/l or 12 nmol/l VEGF for 6 h reduced occludin content 46 and 54%, respectively. These data show that diabetes selectively reduces retinal occludin protein expression and increases BRB permeability. Our findings suggest that the elevated VEGF in the vitreous of patients with diabetic retinopathy increases vascular permeability by downregulating occludin content. Decreased tight junction protein expression may be an important means by which diabetes causes increased vascular permeability and contributes to macular edema.
引用
收藏
页码:1953 / 1959
页数:7
相关论文
共 47 条
  • [1] Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor
    Aiello, LP
    Bursell, SE
    Clermont, A
    Duh, E
    Ishii, H
    Takagi, C
    Mori, F
    Ciulla, TA
    Ways, K
    Jirousek, M
    Smith, LEH
    King, GL
    [J]. DIABETES, 1997, 46 (09) : 1473 - 1480
  • [2] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [3] Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36
  • [4] TIGHT JUNCTIONS AND THE MOLECULAR-BASIS FOR REGULATION OF PARACELLULAR PERMEABILITY
    ANDERSON, JM
    VANITALLIE, CM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 269 (04): : G467 - G475
  • [5] Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein
    Balda, MS
    Whitney, JA
    Flores, C
    Gonzalez, S
    Cereijido, M
    Matter, K
    [J]. JOURNAL OF CELL BIOLOGY, 1996, 134 (04) : 1031 - 1049
  • [6] Barber AJ, 1997, DEV DYNAM, V208, P62, DOI 10.1002/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO
  • [7] 2-#
  • [8] BLAIR NP, 1984, INVEST OPHTH VIS SCI, V25, P302
  • [9] SEROTONIN, NOREPINEPHRINE, AND HISTAMINE MEDIATION OF ENDOTHELIAL-CELL BARRIER FUNCTION-INVITRO
    BOTTARO, D
    SHEPRO, D
    PETERSON, S
    HECHTMAN, HB
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 128 (02) : 189 - 194
  • [10] CARROLL WJ, 1988, INVEST OPHTH VIS SCI, V29, P1201